AMGN

Amgen Inc. News Headlines

$140.46
*  
0.39
0.28%
Get AMGN Alerts
*Delayed - data as of Sep. 30, 2014  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMGN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Celgene Has A Very Bright Future Ahead
9/29/2014 4:26:00 PM - Seeking Alpha

Notable ETF Inflow Detected - XLV, JNJ, AMGN, BMY
9/29/2014 10:52:48 AM - BNK Invest

'Tax Inversions' Are Tip Of An Iceberg That Already Cost The U.S. Treasury Hundreds Of Billions
9/28/2014 2:50:00 AM - Seeking Alpha

Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog
9/26/2014 5:20:00 PM - Zacks.com

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog
9/25/2014 6:27:00 PM - Zacks.com

BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog
9/25/2014 6:24:00 PM - Zacks.com

Acorda Skyrockets on $525M Civitas Therapeutics Deal - Analyst Blog
9/25/2014 5:47:00 PM - Zacks.com

Gilead Scores with TAF-based HIV Regimen, Shares Up - Analyst Blog
9/25/2014 5:20:00 PM - Zacks.com

Inovio/GeneOne Life Science Collaborate for Ebola Vaccine - Analyst Blog
9/25/2014 5:00:00 PM - Zacks.com

ETF Outlook: S&P Health Care Select SPDR ETF (XLV)
9/25/2014 12:31:27 PM - Marc Chaikin

Zacks Rank #1 Additions for Thursday - Tale of the Tape
9/25/2014 9:30:00 AM - Zacks.com

Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
9/24/2014 5:30:00 PM - Zacks.com

3 Top Dividend Growth Stocks to Buy in October
9/24/2014 8:37:07 AM - Motley Fool

Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog
9/23/2014 5:55:00 PM - Zacks.com

Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog
9/23/2014 4:45:00 PM - Zacks.com

Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid - Analyst Blog
9/23/2014 2:54:00 PM - Zacks.com

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
9/23/2014 9:30:00 AM - Zacks.com

Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
9/22/2014 5:45:00 PM - Zacks.com

Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
9/22/2014 3:59:00 PM - Zacks.com

3 Fairly Valued Companies Worthy Of Further Research This Week
9/22/2014 12:43:00 PM - Seeking Alpha

Amgen Submits BLA For Blinatumomab - Quick Facts
9/22/2014 9:16:00 AM - RTT News

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog
9/19/2014 6:25:00 PM - Zacks.com

3 Biotechs Investors Should Watch
9/19/2014 1:49:27 PM - Motley Fool

XLV, JNJ, AMGN, BMY: ETF Inflow Alert
9/19/2014 11:00:14 AM - BNK Invest

Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
9/18/2014 5:35:00 PM - Zacks.com